Research Topics
| Ramsey CheungSummaryAffiliation: Stanford University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?Ramsey C Cheung
VA Palo Alto Healthcare System, Palo Alto, CA 94304, USA
J Clin Gastroenterol 42:827-34. 2008..To determine the validity of fibrosis indexes based on simple laboratory tests in daily practice...
Viral hepatitis and other infectious diseases in a homeless populationRamsey C Cheung
Division of Gastroenterology and Hepatology, VA Palo Alto Health Care System, Palo Alto, California 94304, USA
J Clin Gastroenterol 34:476-80. 2002..To determine the prevalence of four common infectious diseases-hepatitis B, hepatitis C, human immunodeficiency virus (HIV), and tuberculosis-as well as co-infection rates and risk factors in a homeless population...- Effectiveness of a screening program for hepatitis CRamsey C Cheung
Division of Gastroenterology and Hepatology, VA Palo Alto Health Care System 154C, 3801 Miranda Ave, Palo Alto, California 94304, USA
Dig Dis Sci 51:976-81. 2006..Over the following 2 years, some were lost to follow-up, many continued to have contraindication(s) to antiviral therapy, and relatively few were treatment candidates... - The impact of hepatitis C status on postoperative outcomeRamsey C Cheung
Division of Gastroenterology and Hepatology, Cooperative Studies Program Coordinating Center, Department of Anesthesia, VA Palo Alto Health Care System Stanford University, California 94304, USA
Anesth Analg 97:550-4, table of contents. 2003..However, hepatitis C infection was not an independent risk factor for postoperative complications... - Utilization and antiviral therapy in patients with chronic hepatitis C: analysis of ambulatory care visits in the USRamsey Cheung
Division of Gastroenterology and Hepatology, Stanford University, Stanford, CA, USA
Dig Dis Sci 55:1744-51. 2010..Studies on mostly veterans found the majority of chronic hepatitis C (CHC) patients were not treated. Little information exists on a broad-based population... - Positive CAGE screen correlates with cirrhosis in veterans with chronic hepatitis CAhmad Kamal
Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California 94305, USA
Dig Dis Sci 52:2564-9. 2007..6-431) and positive CAGE score (OR = 8.09; 95% CI, 1.15-57.1) were independent predictors of cirrhosis. These findings suggest that the CAGE questionnaire predicts advanced liver disease better than daily or lifetime drinking measures... - Changes in depressive symptoms and impact on treatment course among hepatitis C patients undergoing interferon-α and ribavirin therapy: a prospective evaluationJudith Chapman
Veterans Affairs Palo Alto Health Care System, Psychology Service, Palo Alto, California, USA
Am J Gastroenterol 106:2123-32. 2011.... - Phenotypic and functional status of intrahepatic T cells in chronic hepatitis CJinhui Wang
Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA
J Infect Dis 194:1068-77. 2006..The distinct characteristics of intrahepatic T cells suggest that they play an important role in the immunopathogenesis of chronic hepatitis C... - Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by raceXiao Song He
Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA
Hepatology 44:352-9. 2006.... - Tenofovir monotherapy and tenofovir plus entecavir combination as rescue therapy for entecavir partial respondersBenjamin Yip
Division of Gastroenterology and Hepatology, Stanford University Medical Center, 750 Welch Road, Suite 210, Palo Alto, CA, 94304, USA
Dig Dis Sci 57:3011-6. 2012..Our goal was to examine the complete viral suppression rate (undetectable HBV DNA PCR levels) with alternative therapies in such patients... - Hepatitis C performance measure on hepatitis A and B vaccination: missed opportunities?Bridget Hernandez
Pharmacy Service, VA Palo Alto Health Care System, Palo Alto, California 94304, USA
Am J Gastroenterol 104:1961-7. 2009..This study was conducted to determine adherence to the recently adopted physician performance measure on HAV and HBV vaccination... - Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis CXuhuai Ji
Department of Medicine, Stanford University School of Medicine, Stanford, Palo Alto, CA 94304, USA
Hepatology 37:610-21. 2003..In conclusion, IFN-alpha-inducible genes can be identified in human PBMCs in vivo as well as ex vivo. Signature changes associated with different treatment outcomes may be found among these genes... - Chronic hepatitis C in Latinos: natural history, treatment eligibility, acceptance, and outcomesRamsey C Cheung
VA Palo Alto Healthcare System and Stanford University School of Medicine, Palo Alto, California 94304, USA
Am J Gastroenterol 100:2186-93. 2005..Latino ethnicity was associated with early discontinuation but not as an independent predictor of SVR... - Depression, anxiety, post-traumatic stress, and alcohol-related problems among veterans with chronic hepatitis CCassandra L Lehman
Division of Gastroenterology and Hepatology, Veterans Affairs Palo Alto Health Care System, California 94304, USA
Am J Gastroenterol 97:2640-6. 2002..We recommend a multidisciplinary approach that includes psychological assessment using standardized questionnaires in the evaluation of these patients for antiviral therapy... - A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis CHongjin Huang
Celera Diagnostics, Alameda, CA 94502, USA
Hepatology 46:297-306. 2007..Conclusion: CRS is a better predictor than clinical factors in differentiating high-risk versus low-risk for cirrhosis in Caucasian CHC patients. Prospective studies should be conducted to further validate these findings... - Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis CHongjin Huang
Celera Diagnostics, Alameda, California, USA
Gastroenterology 130:1679-87. 2006..The aim of this study was to identify genetic polymorphisms that can predict the risk of advanced fibrosis in patients with CHC... - Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veteransKe Qin Hu
Loma Linda VA Medical Center, Loma Linda, CA, USA
Dig Dis Sci 52:570-8. 2007..We found that steatosis is independently associated with stage III-IV fibrosis. However, only HCV genotype, and not steatosis, obesity, or stage III-IV fibrosis, was associated with SVR to interferon alpha-2b and ribavirin treatment... - The impact of chronic hepatitis C and comorbid psychiatric illnesses on health-related quality of lifeJoseph K Lim
Division of Gastroenterology and Hepatology, Department of Internal Medicine, VA Palo Alto Health Care System, Palo Alto, California 94304, USA
J Clin Gastroenterol 40:528-34. 2006..In contrast, comorbid depression and PTSD are associated with both lower physical and mental components of HRQol, independent of CHC... - Incidence of statin hepatotoxicity in patients with hepatitis CShirin Khorashadi
Pharmacy Service, VA Palo Alto Health Care System, Palo Alto, California 94304, USA
Clin Gastroenterol Hepatol 4:902-7; quiz 806. 2006..147) were similar in hepatitis C-positive and hepatitis C-negative patients. CONCLUSIONS: Statin therapy was not associated with a higher risk of severe hepatotoxicity in patients with chronic hepatitis C and appeared safe... - Hepatitis B vaccinesAndy S Yu
Liver Transplant Program, Stanford University Medical Center, 750 Welch Road, Suite 210, Stanford, CA 94305, USA
Clin Liver Dis 8:283-300. 2004..For those who remain nonresponders after the second series of vaccination, adjuvants such as GM-CSF may be considered, but their results are variable... - High mortality rate in patients with advanced liver disease independent of exposure to general anesthesiaRamsey C Cheung
Division of Gastroenterology and Hepatology, VA Palo Alto Health Care System, Palo Alto, CA 94304, USA
J Clin Anesth 17:172-6. 2005..Higher survival rates were noted in patients with advanced liver disease who were not thrombocytopenic... - Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis CF Xavier López-Labrador
Department of Medicine Gastroenterology and Hepatology Stanford University School of Medicine, Stanford, California, USA
J Med Virol 72:575-85. 2004..These data may be useful to improve T-cell assays using HCV NS3 peptides, taking into account the genetic diversity of this virus... - The impact of chronic hepatitis C and co-morbid illnesses on health-related quality of lifeJeffrey W Kwan
Division of Gastroenterology and Hepatology, Department of Medicine, VA Palo Alto Health Care System, 154C, 3801 Miranda Avenue, Palo Alto, CA 94304, USA
Qual Life Res 17:715-24. 2008.... - A randomized, double-blind, placebo-controlled dose-escalation trial of merimepodib (VX-497) and interferon-alpha in previously untreated patients with chronic hepatitis CJohn G McHutchison
Duke Clinical Research Institute and Division of Gastroenterology, Duke University Medical Center, Durham, NC, USA
Antivir Ther 10:635-43. 2005..Larger, longer duration trials incorporating pegylated IFN would be required to determine whether this combination, alone or with RBV, would increase either early or sustained virological response rates... - The use of class-I HLA tetramers for the detection of hepatitis C virus NS3-specific CD8(+) T cells in patients with chronic infectionF Xavier López-Labrador
Department of Medicine Gastroenterology and Hepatology, Stanford University School of Medicine, CA 94305, USA
J Immunol Methods 287:91-9. 2004..New methods to detect virus-specific T-cell responses have recently been developed. Several human leukocyte antigen (HLA)-peptide tetramers for the detection of hepatitis C virus (HCV)-specific CD8(+) T cells are under evaluation...